| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 168.97B | 163.11B | 170.34B | 138.59B | 86.38B | 78.37B |
| Gross Profit | 41.59B | 42.20B | 40.79B | 29.98B | 17.24B | 17.45B |
| EBITDA | 21.66B | 21.88B | 23.07B | 36.69B | 9.48B | 10.16B |
| Net Income | 9.54B | 14.03B | 8.76B | 26.32B | 4.32B | 4.33B |
Balance Sheet | ||||||
| Total Assets | 211.46B | 228.95B | 221.59B | 223.40B | 123.73B | 115.71B |
| Cash, Cash Equivalents and Short-Term Investments | 26.71B | 29.11B | 28.02B | 24.44B | 23.82B | 16.21B |
| Total Debt | 18.68B | 14.07B | 20.32B | 20.69B | 10.00B | 10.00B |
| Total Liabilities | 60.86B | 59.28B | 66.92B | 73.98B | 28.75B | 28.63B |
| Stockholders Equity | 142.29B | 160.38B | 145.25B | 140.55B | 88.57B | 81.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.49B | 10.22B | 12.40B | 8.30B | 4.01B |
| Operating Cash Flow | 0.00 | 16.34B | 17.48B | 18.50B | 10.96B | 6.42B |
| Investing Cash Flow | 0.00 | -4.86B | -7.08B | -13.55B | -3.85B | -3.82B |
| Financing Cash Flow | 0.00 | -10.38B | -8.40B | -8.62B | -1.45B | -1.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥101.78B | 7.35 | ― | 3.82% | -4.24% | 61.39% | |
78 Outperform | ¥159.56B | 8.33 | ― | 4.47% | 1.64% | 19.87% | |
75 Outperform | ¥212.54B | 19.50 | 7.50% | 5.39% | -1.82% | 23.07% | |
62 Neutral | ¥107.87B | 23.21 | ― | 3.30% | -1.91% | 7.67% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥55.07B | 4.64 | ― | 0.99% | -0.22% | -2.98% | |
55 Neutral | ¥317.30B | 135.95 | ― | 1.93% | <0.01% | -83.75% |